Can-Fite BioPharma Ltd. Stock-Based Compensation
Can-Fite BioPharma Ltd. (CANF) reported Stock-Based Compensation of $340.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-03-26
| Period end | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $340.00K 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $251.00K 6-K · filed 2025-08-28 | ||
| 2024-12-31 | $362.00K 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $193.00K 6-K · filed 2025-08-28 | ||
| 2023-12-31 | $261.00K 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $95.00K 6-K · filed 2024-08-29 | ||
| 2022-12-31 | $263.00K 20-F · filed 2025-04-14 | ||
| 2022-06-30 | $135.00K 6-K · filed 2023-08-31 | ||
| 2021-12-31 | $466.00K 20-F · filed 2024-03-28 | $68.00K 20-F · filed 2022-03-24 | |
| 2021-06-30 | $166.00K 6-K · filed 2022-08-25 | ||
| 2020-12-31 | $355.00K 20-F · filed 2023-03-30 | ||
| 2020-06-30 | $99.00K 6-K · filed 2021-08-26 | ||
| 2019-12-31 | $385.00K 6-K · filed 2020-06-01 | ||
| 2019-06-30 | $151.00K 6-K · filed 2020-08-27 | ||
| 2018-12-31 | $535.00K 6-K · filed 2020-06-01 | ||
| 2017-12-31 | $192.00K 6-K · filed 2020-06-01 |